Independent Analyses To Inform Go/No-go Decisions
Publié le
Our client in this case was an investment organization specialized in biotechnology companies, and they required an urgent analysis of…
Publié le
Our client in this case was an investment organization specialized in biotechnology companies, and they required an urgent analysis of…
Publié le
Assessment of Clinical Validity of Circulating Tumor Cells (CTC) Quantification Clinical Validity Of Circulating Tumor Cells (CTC) In Patients With…
Publié le
Biostatistical Expertise For Developing New Biomarkers And Diagnostic Tests IDDI has a long-term collaboration with a Sponsor to provide biostatistical…
Publié le
In this meta-analysis, tumor responses and survival were analyzed combining the data from the different trials using patient individual data. The…
Publié le
A new ophthalmic drug was going to enter a phase II dose-ranging trial in order to determine the dose to…
Publié le
Meta-Analysis performed with IDDI’s Methodology Skills IDDI has been involved in numerous meta-analyses to directly or indirectly support new drug applications….
Publié le
Surrogate endpoint for overall survival We managed to prove, using data from a randomized trial comparing Ceplene + IL-2 to…